Apellis Pharmaceuticals Incの1年間の目標

Apellis Pharmaceuticals Incの1年間の目標は何ですか。

Apellis Pharmaceuticals Incの1年間の目標は$53 +37.62%です。

1年間の目標の定義は何ですか。

1年目標は今から1年後の予測株価です。

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

NASDAQのセクタHealth Careにおける1年間の目標の企業と比べるApellis Pharmaceuticals Inc

Apellis Pharmaceuticals Incは何をしますか。

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Apellis Pharmaceuticals Incと類似の1年間の目標